Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: In vivo and in vitro evidence

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Expert Opinion on Investigational Drugs

• Publication date

  2009-05-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/13543780902893051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist.

  2008cited by this paper
• [Modern treatment of erectile dysfunction].

  2008cited by this paper
• Enhancement of bone-bonding ability of bioactive titanium by prostaglandin E2 receptor selective agonist.

  2008cited by this paper
• Reduced COX-2 Expression in Aged Mice Is Associated With Impaired Fracture Healing

  2008cited by this paper
• Tablette, Pumpe oder Spritze?

  2008cited by this paper
• New technologies for the enhancement of skeletal repair.

  2007cited by this paper
• Misoprostol for the treatment of early pregnancy failure

  2007cited by this paper
• Prostaglandin E2 receptors in bone formation

  2007cited by this paper
• Misoprostol for the treatment of early pregnancy failure.

  2007cited by this paper
• Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation.

  2006cited by this paper
• Prostaglandin E2 EP4 receptor-selective agonist facilitates sternal healing after harvesting bilateral internal thoracic arteries in diabetic rats.

  2006influential reference
• Effects of selective prostaglandins E2 receptor agonists on cultured calvarial murine osteoblastic cells.

  2006influential reference
• Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells

  2005cited by this paper
• Repeated Exposure of Tendon to Prostaglandin-E2 Leads to Localized Tendon Degeneration

  2005cited by this paper
• Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading.

  2005influential reference
• Effect of deletion of the prostaglandin EP4 receptor on stimulation of calcium release from cultured mouse calvariae: impaired responsiveness in heterozygotes.

  2005cited by this paper
• A Nonprostanoid EP4 Receptor Selective Prostaglandin E2 Agonist Restores Bone Mass and Strength in Aged, Ovariectomized Rats

  2005influential reference
• Functional pharmacology of human prostanoid EP2 and EP4 receptors.

  2004cited by this paper
• Biphasic Effect of Prostaglandin E2 on Osteoclast Formation in Spleen Cell Cultures: Role of the EP2 Receptor

  2004influential reference
• A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro.

  2004cited by this paper
• Stimulation of cAMP production and cyclooxygenase-2 by prostaglandin E(2) and selective prostaglandin receptor agonists in murine osteoblastic cells.

  2004influential reference
• Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats.

  2004cited by this paper
• A Novel, Non‐Prostanoid EP2 Receptor‐Selective Prostaglandin E2 Agonist Stimulates Local Bone Formation and Enhances Fracture Healing

  2003influential reference
• Discovery of a potent and selective agonist of the prostaglandin EP4 receptor.

  2003cited by this paper
• An EP2 receptor-selective prostaglandin E2 agonist induces bone healing

  2003cited by this paper
• Effects of selective prostaglandin EP2 and EP4 receptor agonists on bone resorption and formation in fetal rat organ cultures.

  2003influential reference
• Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice.

  2002cited by this paper
• Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair.

  2002cited by this paper
• Design and synthesis of a selective EP4-receptor agonist. Part 3: 16-phenyl-5-thiaPGE(1) and 9-beta-halo derivatives with improved stability.

  2002cited by this paper
• Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation

  2002influential reference
• Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2).

  2001influential reference
• Expression of the prostaglandin E(2) (PGE(2)) receptor subtype EP(4) and its regulation by PGE(2) in osteoblastic cell lines and adult rat bone tissue.

  2001cited by this paper
• Characterization of the prostaglandin receptors in human osteoblasts in culture.

  2001influential reference
• Bone anabolic therapy with selective prostaglandin analogs.

  2001cited by this paper
• Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice.

  2001cited by this paper
• Prostanoid receptors: subtypes and signaling.

  2001cited by this paper
• Prostaglandin E2 Regulates the Level and Stability of Cyclooxygenase-2 mRNA through Activation of p38 Mitogen-activated Protein Kinase in Interleukin-1β-treated Human Synovial Fibroblasts*

  2001cited by this paper
• Expression of the prostaglandin E2 (PGE2) receptor subtype EP4 and its regulation by PGE2 in osteoblastic cell lines and adult rat bone tissue1

  2001cited by this paper
• Prostaglandin E2 Directly Inhibits Bone-Resorbing Activity of Isolated Mature Osteoclasts Mainly Through the EP4 Receptor

  2000influential reference
• Crucial Involvement of the EP4 Subtype of Prostaglandin E Receptor in Osteoclast Formation by Proinflammatory Cytokines and Lipopolysaccharide

  2000cited by this paper
• Cyclooxygenase-2 Expression in Lipopolysaccharide-Stimulated Human Monocytes Is Modulated by Cyclic AMP, Prostaglandin E2, and Nonsteroidal Anti-inflammatory Drugs☆

  2000cited by this paper
• Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs.

  2000cited by this paper
• The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.

  2000influential reference
• Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.

  2000cited by this paper
• Prostanoid receptors: structures, properties, and functions.

  1999influential reference
• The anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype.

  1999cited by this paper
• Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia.

  1998cited by this paper
• Prostaglandin E Receptor Subtypes in Mouse Osteoblastic Cell Line(マウス骨芽細胞株に於けるプロスタグランディンE受容体サブタイプ)

  1998cited by this paper
• A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro.

  1998cited by this paper
• Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2.

  1998influential reference
• Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes.

  1997influential reference
• Molecular cloning and expression of a rat prostaglandin E2 receptor of the EP2 subtype.

  1997cited by this paper
• Prostaglandin E2 stimulates osteoclast‐like cell formation and bone‐resorbing activity via osteoblasts: Role of cAMP‐dependent protein kinase

  1996cited by this paper
• Prostaglandin E receptor subtypes in mouse osteoblastic cell line.

  1996cited by this paper
• Expression of prostaglandin E receptor subtypes in bone: expression of EP2 in bone development.

  1995cited by this paper
• Modulation of osteoclast differentiation by local factors.

  1995cited by this paper
• The role of prostaglandins in the regulation of bone metabolism.

  1995cited by this paper
• Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease.

  1994cited by this paper
• Noninvasive loading of the rat ulna in vivo induces a strain-related modeling response uncomplicated by trauma or periostal pressure

  1994cited by this paper
• Chrome congestive heart failureStudy of low dosage prostaglandin—usages and complications

  1994cited by this paper
• A noninvasive, in vivo model for studying strain adaptive bone modeling.

  1991cited by this paper
• Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs.

  1990cited by this paper
• Bone repair inhibited by indomethacin. Effects on bone metabolism and strength of rabbit osteotomies.

  1987cited by this paper
• Prostaglandin E2 stimulates DNA synthesis by a cyclic AMP‐independent pathway in osteoblastic clone MC3T3‐E1 cells

  1986cited by this paper
• Release of prostaglandins from bone and muscle after tibial fracture. An experimental study in rabbits.

  1981cited by this paper
• Cyclic AMP production in rat calvaria in vitro: interaction prostaglandins with parathyroid hormone.

  1977cited by this paper
• Effects of prostaglandins and other drugs on the cyclic AMP content of cultured bone cells.

  1976cited by this paper
• The effect of parathyroid hormone on the concentration of adenosine 3',5'-monophosphate in skeletal tissue in vitro.

  1970cited by this paper
• Printed in U.S.A. Copyright © 2000 by The Endocrine Society Knockout of the Murine Prostaglandin EP 2 Receptor Impairs Osteoclastogenesis in Vitro*

  year unknowninfluential reference

• Exploring an innovative augmentation strategy in spinal fusion: A novel selective prostaglandin EP4 receptor agonist as a potential osteopromotive factor to enhance lumbar posterolateral fusion.

  2025cites this paper
• Modern Approaches and Emerging Biological Therapies to Treat Fracture Nonunion

  2025cites this paper
• Kefir peptides promote osteogenic differentiation to enhance bone fracture healing in rats.

  2022cites this paper
• Factors secreted by monosodium urate crystal-stimulated macrophages promote a proinflammatory state in osteoblasts: a potential indirect mechanism of bone erosion in gout

  2022cites this paper
• Anti-Inflammatory and Chondro-Protective Effects of Acidic Polysaccharide from Enteromorpha Prolifera in Experimental Models of Osteoarthritis In-Vitro and In-Vivo

  2022cites this paper
• Control of osteoblast arrangement by osteocyte mechanoresponse through prostaglandin E2 signaling under oscillatory fluid flow stimuli.

  2021cites this paper
• Molecular characterization of the prostaglandin E receptor subtypes 2a and 4b and their expression patterns during embryogenesis in zebrafish.

  2021cites this paper
• Cytokine “fine tuning” of enthesis tissue homeostasis as a pointer to spondyloarthritis pathogenesis with a focus on relevant TNF and IL-17 targeted therapies

  2021cites this paper
• Cardamonin Attenuates Inflammation and Oxidative Stress in Interleukin-1β-Stimulated Osteoarthritis Chondrocyte through the Nrf2 Pathway

  2021cites this paper
• Crosstalk between the COX2‐PGE2‐EP4 signaling pathway and primary cilia in osteoblasts after mechanical stimulation

  2020cites this paper
• Improved bone regeneration using bone anabolic drug conjugates (C3 and C6) with deproteinized bovine bone mineral as a carrier in rat mandibular defects.

  2020cites this paper
• International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1–4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions

  2020cites this paper
• Dose-dependent roles of aspirin and other non-steroidal anti-inflammatory drugs in abnormal bone remodeling and skeletal regeneration

  2019cites this paper
• Adjuvant drug-assisted bone healing: Part I – Modulation of inflammation

  2019cites this paper
• New Targets and Emergent Therapies for Osteoporosis.

  2019cites this paper
• The Biological Enhancement of Spinal Fusion for Spinal Degenerative Disease

  2018cites this paper
• Aminothiazoles inhibit osteoclastogenesis and PGE 2 production in LPS‐stimulated co‐cultures of periodontal ligament and RAW 264.7 cells, and RANKL‐mediated osteoclastogenesis and bone resorption in PBMCs

  2018cites this paper
• Mori folium inhibits interleukin-1β-induced expression of matrix metalloproteinases and inflammatory mediators by suppressing the activation of NF-κB and p38 MAPK in SW1353 human chondrocytes.

  2016cites this paper
• Meloxicam temporally inhibits the expression of vascular endothelial growth factor receptor (VEGFR)-1 and VEGFR-2 during alveolar bone repair in rats.

  2015cites this paper
• Complications rachidiennes de la spondyloarthrite ankylosante

  2015cites this paper
• Local drug delivery for enhancing fracture healing in osteoporotic bone.

  2015cites this paper
• Knochendichte von Kindern mit antenatalem Bartter-Syndrom (Hyperprostaglandin-E-Syndrom)- Vergleich mit ehemaligen Frühgeborenen

  2014cites this paper
• Resolving an inflammatory concept: The importance of inflammation and resolution in tendinopathy

  2014cites this paper
• Inflammatory pathways in spondyloarthritis.

  2014cites this paper
• Bone defects in LPA receptor genetically modified mice.

  2013cites this paper
• The growing role of eicosanoids in tissue regeneration, repair, and wound healing.

  2013cites this paper
• PGE₂ and BMP-2 in bone and cartilage metabolism: 2 intertwining pathways.

  2012cites this paper
• Osteoblasts and their Signaling Pathways: New Frontiers for Linkage to the Immune System

  2011cites this paper
• Noncanonical BMP signaling regulates cyclooxygenase-2 transcription.

  2011cites this paper
• Endogenous prostaglandin E2 inhibits aberrant overgrowth of rheumatoid synovial tissue and the development of osteoclast activity through EP4 receptor.

  2011cites this paper
• The prostaglandin E(2) system: a toolbox for skeletal repair?

  2011cites this paper